Pharma Mar SA
MAD:PHM
Pharma Mar SA
MAD:PHM
Price:
36.72 EUR
1.32%
Market Closed
Updated:
May 19, 2024
Section:
Relative Value
The Relative Value of one
PHM
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 36.72 EUR,
Pharma Mar SA
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PHM Relative Value
HIDDEN
Valuation Multiples
Multiples Across Competitors
PHM Competitors Multiples
Pharma Mar SA Competitors
Pharma Mar SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| ES |
|
Pharma Mar SA
MAD:PHM
|
647.7m EUR | 4 | 319.7 | 2 726.4 | -90.2 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
293.9B USD | 5.4 | 49.4 | 13.8 | 21.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
167.6B USD | 5.7 | 44.5 | 18.7 | 30.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
115B USD | 11.3 | 28.6 | 24 | 25.1 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108.2B USD | 8.3 | 28.1 | 22.7 | 25.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
135.3B AUD | 6.4 | 36.6 | 22.1 | 27.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
84.4B USD | 3.1 | 174.3 | 8.8 | 11.6 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
50.9B USD | 9.9 | -8.5 | -9.4 | -8.4 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
33.6B USD | 3.5 | 28.8 | 14.6 | 18.3 | |
| KR |
|
Celltrion Inc
KRX:068270
|
39.7T KRW | 18.2 | 74.1 | 45.3 | 62.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
